Stay updated with breaking news from Jean Philippe Seta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
France's Servier laboratories group, which marketed Mediator – a drug used as an appetite suppressant and accused of causing serious cardiovascular damage – has been fined more than €7 million on appeal…
A French appeals court ordered Servier Pharmaceutical to pay damages totaling over $460 million in connection with a more than ten-year-long diabetes drug scandal.
The manufacturer of this antidiabetic drug was found guilty of aggravated deceit and involuntary manslaughter but acquitted of fraud and improperly obtained marketing authorization.
It comes after the manufacturing lab was found guilty of aggravated deception and manslaughter in connection with the drug which has been linked to hundreds of deaths
The company was fined 2.7 million euros ($2.88 million) for concealing Mediator's risks, and ordered to pay more than 180 million euros in compensation and interest to victims. Servier is appealing more than half a dozen convictions against the company and former head of operations Jean-Philippe Seta, including for manslaughter with wilful misconduct, involuntary injury, fraud and deception.